OraSure Technologies Share Holder Equity 2012-2025 | OSUR

OraSure Technologies share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
OraSure Technologies Annual Share Holder Equity
(Millions of US $)
2024 $410
2023 $431
2022 $364
2021 $381
2020 $399
2019 $307
2018 $283
2017 $258
2016 $186
2015 $159
2014 $159
2013 $161
2012 $170
2011 $100
OraSure Technologies Quarterly Share Holder Equity
(Millions of US $)
2025-09-30 $362
2025-06-30 $381
2025-03-31 $396
2024-12-31 $410
2024-09-30 $426
2024-06-30 $426
2024-03-31 $426
2023-12-31 $431
2023-09-30 $405
2023-06-30 $394
2023-03-31 $394
2022-12-31 $364
2022-09-30 $342
2022-06-30 $344
2022-03-31 $365
2021-12-31 $381
2021-09-30 $388
2021-06-30 $405
2021-03-31 $404
2020-12-31 $399
2020-09-30 $388
2020-06-30 $382
2020-03-31 $290
2019-12-31 $307
2019-09-30 $301
2019-06-30 $288
2019-03-31 $281
2018-12-31 $283
2018-09-30 $277
2018-06-30 $265
2018-03-31 $259
2017-12-31 $258
2017-09-30 $250
2017-06-30 $229
2017-03-31 $209
2016-12-31 $186
2016-09-30 $176
2016-06-30 $169
2016-03-31 $163
2015-12-31 $159
2015-09-30 $160
2015-06-30 $160
2015-03-31 $156
2014-12-31 $159
2014-09-30 $161
2014-06-30 $160
2014-03-31 $155
2013-12-31 $161
2013-09-30 $155
2013-06-30 $155
2013-03-31 $160
2012-12-31 $170
2012-09-30 $175
2012-06-30 $99
2012-03-31 $100
2011-12-31 $100
2011-09-30 $96
2011-06-30 $101
2011-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.197B $0.186B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.936B 21.88
EssilorLuxottica (ESLOY) France $142.091B 0.00
Stryker (SYK) United States $140.083B 26.86
Medtronic (MDT) Ireland $127.548B 17.67
Boston Scientific (BSX) United States $110.783B 24.50
Medline (MDLN) United States $58.526B 0.00
Lonza Group Ag (LZAGY) Switzerland $48.093B 0.00
ResMed (RMD) United States $36.791B 24.57
GE HealthCare Technologies (GEHC) United States $36.615B 17.54
Agilent Technologies (A) United States $35.584B 22.55
Koninklijke Philips (PHG) Netherlands $30.091B 17.86
Terumo (TRUMY) Japan $21.610B 25.26
Zimmer Biomet Holdings (ZBH) United States $19.115B 11.76
Insulet (PODD) United States $17.076B 53.00
Smith & Nephew SNATS (SNN) United Kingdom $15.372B 0.00
Baxter (BAX) United States $10.182B 8.72
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $6.921B 25.86
Demant (WILYY) Denmark $6.042B 0.00
Envista Holdings (NVST) United States $4.747B 24.14
Lantheus Holdings (LNTH) United States $4.601B 14.02
BillionToOne (BLLN) United States $4.056B 0.00
ICU Medical (ICUI) United States $3.577B 22.71
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.160B 14.91
Haemonetics (HAE) United States $2.684B 11.74
Neogen (NEOG) United States $2.380B 52.10
Phibro Animal Health (PAHC) United States $2.118B 18.66
Perrigo (PRGO) Ireland $2.001B 5.01
LeMaitre Vascular (LMAT) United States $1.989B 40.03
Curaleaf Holdings (CURLF) Canada $1.642B 0.00
AtriCure (ATRC) United States $1.623B 0.00
QuidelOrtho (QDEL) United States $1.602B 11.12
Kestra Medical Technologies (KMTS) United States $1.571B 0.00
Green Thumb Industries (GTBIF) United States $1.446B 63.36
AdaptHealth (AHCO) United States $1.381B 20.00
Lumexa Imaging Holdings (LMRI) United States $1.358B 0.00
BioLife Solutions (BLFS) United States $1.070B 317.57
Capricor Therapeutics (CAPR) United States $1.026B 0.00
InMode (INMD) Israel $0.906B 9.93
Tilray Brands (TLRY) Canada $0.875B 0.00
Valneva SE (VALN) France $0.868B 0.00
Omeros (OMER) United States $0.829B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.757B 0.00
CeriBell (CBLL) United States $0.733B 0.00
VAREX IMAGING (VREX) United States $0.566B 13.52
Brainsway (BWAY) Israel $0.451B 76.63
Canopy Growth (CGC) Canada $0.436B 0.00
Cerus (CERS) United States $0.430B 0.00
Verano Holdings (VRNO) United States $0.396B 0.00
SNDL (SNDL) Canada $0.386B 0.00
Cresco Labs (CRLBF) United States $0.361B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.328B 0.00
Viemed Healthcare (VMD) United States $0.315B 25.09
Evolus (EOLS) United States $0.279B 0.00
Quanterix (QTRX) United States $0.268B 0.00
TriSalus Life Sciences (TLSI) United States $0.243B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Sanuwave Health (SNWV) United States $0.213B 0.00
Utah Medical Products (UTMD) United States $0.205B 18.42
High Tide (HITI) Canada $0.203B 0.00
Aurora Cannabis (ACB) Canada $0.201B 59.17
TerrAscend (TSNDF) Canada $0.182B 0.00
Organigram Global (OGI) Canada $0.174B 0.00
Accendra Health (ACH) United States $0.173B 1.74
Vireo Growth (VREOF) United States $0.170B 0.00
Sanara MedTech (SMTI) United States $0.168B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.142B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.129B 0.00
Fonar (FONR) United States $0.115B 16.42
MacroGenics (MGNX) United States $0.108B 0.00
Jushi Holdings (JUSHF) United States $0.100B 0.00
Biote (BTMD) United States $0.097B 4.26
Exagen (XGN) United States $0.074B 0.00
ImmuCell (ICCC) United States $0.060B 25.39
Sharps Technology (STSS) United States $0.051B 0.00
Nephros (NEPH) United States $0.044B 31.54
Cytosorbents (CTSO) United States $0.040B 0.00
Rockwell Medical (RMTI) United States $0.040B 0.00
Veru (VERU) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
United-Guardian (UG) United States $0.030B 15.35
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
INLIF (INLF) China $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Agape ATP (ATPC) $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00